Persistent COVID-19 Pneumonia and Failure to Develop Anti-SARS-CoV-2 Antibodies During Rituximab Maintenance Therapy for Follicular Lymphoma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2020-11, Vol.20 (11), p.774-776
Hauptverfasser:	Yasuda, Hajime, Tsukune, Yutaka, Watanabe, Naoki, Sugimoto, Kazuya, Uchimura, Ayana, Tateyama, Misa, Miyashita, Yosuke, Ochi, Yusuke, Komatsu, Norio
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Neutralizing - blood Antibodies, Neutralizing - immunology Antibodies, Viral - blood Antibodies, Viral - immunology Antineoplastic Agents, Immunological - adverse effects Atypical presentation Betacoronavirus - immunology Betacoronavirus - isolation & purification Case Report CHOP Chronic Disease Coronavirus Coronavirus Infections - blood Coronavirus Infections - complications Coronavirus Infections - diagnosis Coronavirus Infections - immunology COVID-19 Female Hematological malignancy Humans Lung - diagnostic imaging Lymphoma, Follicular - complications Lymphoma, Follicular - drug therapy Lymphoma, Follicular - immunology Middle Aged Obinutuzumab Pandemics Pneumonia, Viral - blood Pneumonia, Viral - complications Pneumonia, Viral - diagnosis Pneumonia, Viral - immunology Rituximab - adverse effects SARS-CoV-2 Tomography, X-Ray Computed
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!